James C. Clemmer

James C. Clemmer is a declared insider of Angiodynamics Inc (chief executive), with filings sourced from SEC (Form 4). We count 36 filings; the first trade dates from 14 July 2021 and the latest from 22 July 2026.

Every open-market trade on record is a purchase: 5 purchases worth €624k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 24 share grants and 7 option exercises.

The median purchase comes to €110k. 2 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 24 July 2026 with an option exercise in Angiodynamics Inc. The last purchase on record was published on 9 October 2025, which is 374 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.